Home Featured Page 285

Featured

Latest

Megan Portnoy MS – Ontological Design, Psychedelic Spaces, and Integrating Rigor

The Psychedelic News Feed: October 6 – 12, 2025

Recovered or Reimagined? Samuli Kangaslampi on Psychedelics and Autobiographical Recall

Psychedelic Futures – Nowak Society featuring Joe Moore

Q2 2025: Oregon Psilocybin Services Update

Joe Rogan: Dedemonizing Psychedelics

PsyBio Completes Reverse Take-Over Transaction

Psychedelic Business News Spotlight: February 19, 2021

Psychedelic Bulletin: California Bill Aims to Decriminalize Psychedelics; MindMed Acquires HealthMode;...

Differentiating DMT and Near-Death Experiences

New Texas Legislation Will Allow State to Study MDMA, Psilocybin as...

Algernon Pharmaceuticals Awards DMT Manufacturing Contract to Dalton Pharma for Stroke...

PTSF47 – Covid, Ketamine, and Human Rights

Massachusetts General Hospital to Study How Psychedelics Influence the Brain

Can LSD cure our pandemic anxiety? MindMed is spending big to...

1...284285286...299 Page 285 of 299

Megan Portnoy MS – Ontological Design, Psychedelic Spaces, and Integrating Rigor

The Psychedelic News Feed: October 6 – 12, 2025

Recovered or Reimagined? Samuli Kangaslampi on Psychedelics and Autobiographical Recall

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Megan Portnoy MS – Ontological Design, Psychedelic Spaces, and Integrating Rigor

The Psychedelic News Feed: October 6 – 12, 2025

Recovered or Reimagined? Samuli Kangaslampi on Psychedelics and Autobiographical Recall

Psychedelic Futures – Nowak Society featuring Joe Moore

Q2 2025: Oregon Psilocybin Services Update

Joe Rogan: Dedemonizing Psychedelics

PsyBio Completes Reverse Take-Over Transaction

Psychedelic Business News Spotlight: February 19, 2021

Psychedelic Bulletin: California Bill Aims to Decriminalize Psychedelics; MindMed Acquires HealthMode;...

Differentiating DMT and Near-Death Experiences

New Texas Legislation Will Allow State to Study MDMA, Psilocybin as...

Algernon Pharmaceuticals Awards DMT Manufacturing Contract to Dalton Pharma for Stroke...

PTSF47 – Covid, Ketamine, and Human Rights

Massachusetts General Hospital to Study How Psychedelics Influence the Brain

Can LSD cure our pandemic anxiety? MindMed is spending big to...

EDITOR PICKS

Megan Portnoy MS – Ontological Design, Psychedelic Spaces, and Integrating Rigor

The Psychedelic News Feed: October 6 – 12, 2025

Recovered or Reimagined? Samuli Kangaslampi on Psychedelics and Autobiographical Recall

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY